Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://www.nature.com/articles/s41571-023-00760-3.pdf
Reference126 articles.
1. Tsimberidou, A. M., Fountzilas, E., Nikanjam, M. & Kurzrock, R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat. Rev. 86, 102019 (2020).
2. Curigliano, G. et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann. Oncol. 28, 1700–1712 (2017).
3. Kim, E. S. & Pandya, K. J. Advances in personalized therapy for lung cancer. Expert. Opin. Med. Diagn. 7, 475–485 (2013).
4. Duan, L., Mukherjee, E. M. & Narayan, D. Tailoring the treatment of melanoma: implications for personalized medicine. Yale J. Biol. Med. 88, 389–395 (2015).
5. Eggermont, A. M. et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(15)70122-1 (2015).
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ion-interferential cell cycle arrest for melanoma treatment based on magnetocaloric bimetallic-ion sustained release hydrogel;Chinese Chemical Letters;2024-02
2. Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages;Nano Letters;2024-01-25
3. Mapping the single cell spatial immune landscapes of the melanoma microenvironment;Clinical & Experimental Metastasis;2024-01-13
4. Quoi de neuf en oncodermatologie ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12
5. Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma;Cancer Discovery;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3